Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 1486 AL 1500

Memantine hydrochloride in the treatment of dementia subtypes

Peng D, Yuan X, Zhu R.

J Clin Neurosci. 2013 Nov;20(11):1482-5. doi: 10.1016/j.jocn.2013.02.041. Epub 2013 Sep 13.

The nucleus basalis of Meynert: a new target for deep brain stimulation in dementia?

Gratwicke J, Kahan J, Zrinzo L, Hariz M, Limousin P, Foltynie T, Jahanshahi M.

Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2676-88. doi: 10.1016/j.neubiorev.2013.09.003. Epub 2013 Sep 11.

Electrocardiographic screening of 1-month-old infants for identifying prolonged QT intervals

Yoshinaga M, Ushinohama H, Sato S, Tauchi N, Horigome H, Takahashi H, Sumitomo N, Kucho Y, Shiraishi H, Nomura Y, Shimizu W, Nagashima M.

Circ Arrhythm Electrophysiol. 2013 Oct;6(5):932-8. doi: 10.1161/CIRCEP.113.000619. Epub 2013 Sep 13.

Neurotranmission systems as targets for toxicants: a review

Marrs TC, Maynard RL.

Cell Biol Toxicol. 2013 Dec;29(6):381-96. doi: 10.1007/s10565-013-9259-9. Epub 2013 Sep 15.

Therapeutic prospects for Parkinson disease

Olanow CW, Schapira AH.

Ann Neurol. 2013 Sep;74(3):337-47. doi: 10.1002/ana.24011.

Targeting striatal metabotropic glutamate receptor type 5 in Parkinson's disease: bridging molecular studies and clinical trials

Vallano A, Fernandez-Duenas V, Garcia-Negredo G, Quijada MA, Simon CP, Cuffí ML, Carbonell L, Sanchez S, Arnau JM, Ciruela F.

CNS Neurol Disord Drug Targets. 2013 Dec;12(8):1128-42.

Induced pluripotent stem cell-based studies of Parkinson's disease: challenges and promises

Sanchez-Danes A, Benzoni P, Memo M, Dell'Era P, Raya A, Consiglio A.

CNS Neurol Disord Drug Targets. 2013 Dec;12(8):1114-27.

Overlapping molecular signatures in Parkinson's patients' leukocytes before and after treatment and in mouse model brain regions

Soreq L, Bergman H, Israel Z, Soreq H.

CNS Neurol Disord Drug Targets. 2013 Dec;12(8):1086-93.

Receptor heteromers in Parkinson's disease and L-DOPA-induced dyskinesia

Fiorentini C, Savoia P, Savoldi D, Missale C.

CNS Neurol Disord Drug Targets. 2013 Dec;12(8):1101-13.

Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: surgical technique, tips, tricks and complications

Kocabicak E, Temel Y.

Clin Neurol Neurosurg. 2013 Nov;115(11):2318-23. doi: 10.1016/j.clineuro.2013.08.020. Epub 2013 Aug 29.

The serotonin 5-HT7 receptors: two decades of research

Gellynck E, Heyninck K, Andressen KW, Haegeman G, Levy FO, Vanhoenacker P, Van Craenenbroeck K.

Exp Brain Res. 2013 Oct;230(4):555-68. doi: 10.1007/s00221-013-3694-y. Epub 2013 Sep 17.

A severe and irreversible case of tardive rigid-akinetic parkinsonian syndrome: the role of the DaTscan

Politis AM, Kokras N, Pappa D, Siarkos C, Katirtzoglou E, Papadimitriou GN, Kahn DA.

J Psychiatr Pract. 2013 Sep;19(5):413-8. doi: 10.1097/01.pra.0000435041.13921.a8.

[Cardiac sympathetic innervation imaging with myocardial MIBG scintigraphy]

Genovese EA, Mallardo V, Cipullo S, Restuccia A, Galea D, D'Agosto G, Di Lanno I, Cappabianca S.

Recenti Prog Med. 2013 Jul-Aug;104(7-8):356-60. doi: 10.1701/1315.14575.

[Correlation between cognitive impairment and plasma levels of clusterin/ApoJ in Parkinson disease patients not affected by dementia]

Niccoli Asabella A, Ruggeri M, Rubini D, Polimeno L, Spinelli C, Polito M, Pennelli M, Altini C, De Caro MS, Defazio G, Rubini G.

Recenti Prog Med. 2013 Jul-Aug;104(7-8):393-7. doi: 10.1701/1315.14582.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias